Prosecution Insights
Last updated: August 18, 2026

Purdue Pharma L.P.

5 pending office actions • 4 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Portfolio Summary

5
Total Pending OAs
2
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
5
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only4 (80%)
Double-patenting + other1 (20%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
80% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
20% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HAM, JIEUN 1 50.0% +62.5%
SHTERENGARTS, SAMANTHA L 1 79.3% +8.0%
ABDALHAMEED, MANAHIL MIRGHANI ALI 1 50.4% +40.1%
MACH, ANDRE 1 45.9% +53.2%
COPPINS, JANET L 1 72.9% +25.5%

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18420883 COMBINATIONS FOR TREATING CANCER HAM, JIEUN
18017767 COMPOSITIONS AND METHODS FOR LEVODOPA DELIVERY ABDALHAMEED, MANAHIL MIRGHANI ALI
17918012 COMPOSITIONS AND METHODS FOR EMERGENCY RESCUE MACH, ANDRE
17059761 COMPOSITIONS AND METHODS FOR OPIOID OVERDOSE RESCUE COPPINS, JANET L

Top Art Units

Art UnitApps
1623 1
1622 1
1615 1
1628 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18420883 COMBINATIONS FOR TREATING CANCER HAM, JIEUN §103 Non-Final OA Pending Jan 24, 2024
18561405 METHODS OF TREATING INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME SHTERENGARTS, SAMANTHA L 1623 §103DPOther Non-Final OA Pending Nov 16, 2023
18017767 COMPOSITIONS AND METHODS FOR LEVODOPA DELIVERY ABDALHAMEED, MANAHIL MIRGHANI ALI 1622 §103 Final Rejection Pending Jan 24, 2023
17918012 COMPOSITIONS AND METHODS FOR EMERGENCY RESCUE MACH, ANDRE 1615 §103 Final Rejection Pending Oct 10, 2022
17059761 COMPOSITIONS AND METHODS FOR OPIOID OVERDOSE RESCUE COPPINS, JANET L 1628 §103 Final Rejection Pending Nov 30, 2020

Managing Purdue Pharma L.P.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month